Third Avenue Management started to build up the position in Haemonetics in Q2 2013. Since then they sold 42 Thousand shares. The investor sold all their shares in Q4 2013 and doesn't own any shares in Haemonetics anymore.
Haemonetics faces near-term revenue growth challenges due to the loss of its plasma collections business with CSL over the next two years. Management has use...
Haemonetics (NYSE: HAE ) has been gaining from business growth within Plasma, Hospital and Hemostasis Management. Its new launches also aid growth. The stock...
Martingale Asset Management L P boosted its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 3.8% during the first quarter, Holdings Channel...
Victory Capital Management Inc. grew its position in Haemonetics Co. by 808.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The ...